Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

Neil H. Riordan, Thomas E. Ichim, Wei Ping Min, Hao Wang, Fabio Solano, Fabian Lara, Miguel Alfaro, Jorge Paz Rodriguez, Robert J. Harman, Amit N. Patel, Michael Murphy, Roland R. Lee, Boris Minev

Research output: Contribution to journalArticle

210 Citations (Scopus)

Abstract

The stromal vascular fraction (SVF) of adipose tissue is known to contain mesenchymal stem cells (MSC), T regulatory cells, endothelial precursor cells, preadipocytes, as well as anti-inflammatory M2 macrophages. Safety of autologous adipose tissue implantation is supported by extensive use of this procedure in cosmetic surgery, as well as by ongoing studies using in vitro expanded adipose derived MSC. Equine and canine studies demonstrating anti-inflammatory and regenerative effects of non-expanded SVF cells have yielded promising results. Although non-expanded SVF cells have been used successfully in accelerating healing of Crohn's fistulas, to our knowledge clinical use of these cells for systemic immune modulation has not been reported. In this communication we discuss the rationale for use of autologous SVF in treatment of multiple sclerosis and describe our experiences with three patients. Based on this rationale and initial experiences, we propose controlled trials of autologous SVF in various inflammatory conditions.

Original languageEnglish
Article number29
JournalJournal of Translational Medicine
Volume7
DOIs
StatePublished - Apr 24 2009

Fingerprint

Cell- and Tissue-Based Therapy
Stem cells
Multiple Sclerosis
Blood Vessels
Anti-Inflammatory Agents
Tissue
Macrophages
Endothelial cells
Surgery
Mesenchymal Stromal Cells
Modulation
Adipose Tissue
Communication
Regulatory T-Lymphocytes
Plastic Surgery
Horses
Fistula
Canidae
Endothelial Cells
Safety

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Riordan, N. H., Ichim, T. E., Min, W. P., Wang, H., Solano, F., Lara, F., ... Minev, B. (2009). Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. Journal of Translational Medicine, 7, [29]. https://doi.org/10.1186/1479-5876-7-29

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. / Riordan, Neil H.; Ichim, Thomas E.; Min, Wei Ping; Wang, Hao; Solano, Fabio; Lara, Fabian; Alfaro, Miguel; Rodriguez, Jorge Paz; Harman, Robert J.; Patel, Amit N.; Murphy, Michael; Lee, Roland R.; Minev, Boris.

In: Journal of Translational Medicine, Vol. 7, 29, 24.04.2009.

Research output: Contribution to journalArticle

Riordan, NH, Ichim, TE, Min, WP, Wang, H, Solano, F, Lara, F, Alfaro, M, Rodriguez, JP, Harman, RJ, Patel, AN, Murphy, M, Lee, RR & Minev, B 2009, 'Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis', Journal of Translational Medicine, vol. 7, 29. https://doi.org/10.1186/1479-5876-7-29
Riordan, Neil H. ; Ichim, Thomas E. ; Min, Wei Ping ; Wang, Hao ; Solano, Fabio ; Lara, Fabian ; Alfaro, Miguel ; Rodriguez, Jorge Paz ; Harman, Robert J. ; Patel, Amit N. ; Murphy, Michael ; Lee, Roland R. ; Minev, Boris. / Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. In: Journal of Translational Medicine. 2009 ; Vol. 7.
@article{a7b3fe26fbd6487c9dcb0069a7b99073,
title = "Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis",
abstract = "The stromal vascular fraction (SVF) of adipose tissue is known to contain mesenchymal stem cells (MSC), T regulatory cells, endothelial precursor cells, preadipocytes, as well as anti-inflammatory M2 macrophages. Safety of autologous adipose tissue implantation is supported by extensive use of this procedure in cosmetic surgery, as well as by ongoing studies using in vitro expanded adipose derived MSC. Equine and canine studies demonstrating anti-inflammatory and regenerative effects of non-expanded SVF cells have yielded promising results. Although non-expanded SVF cells have been used successfully in accelerating healing of Crohn's fistulas, to our knowledge clinical use of these cells for systemic immune modulation has not been reported. In this communication we discuss the rationale for use of autologous SVF in treatment of multiple sclerosis and describe our experiences with three patients. Based on this rationale and initial experiences, we propose controlled trials of autologous SVF in various inflammatory conditions.",
author = "Riordan, {Neil H.} and Ichim, {Thomas E.} and Min, {Wei Ping} and Hao Wang and Fabio Solano and Fabian Lara and Miguel Alfaro and Rodriguez, {Jorge Paz} and Harman, {Robert J.} and Patel, {Amit N.} and Michael Murphy and Lee, {Roland R.} and Boris Minev",
year = "2009",
month = "4",
day = "24",
doi = "10.1186/1479-5876-7-29",
language = "English",
volume = "7",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

AU - Riordan, Neil H.

AU - Ichim, Thomas E.

AU - Min, Wei Ping

AU - Wang, Hao

AU - Solano, Fabio

AU - Lara, Fabian

AU - Alfaro, Miguel

AU - Rodriguez, Jorge Paz

AU - Harman, Robert J.

AU - Patel, Amit N.

AU - Murphy, Michael

AU - Lee, Roland R.

AU - Minev, Boris

PY - 2009/4/24

Y1 - 2009/4/24

N2 - The stromal vascular fraction (SVF) of adipose tissue is known to contain mesenchymal stem cells (MSC), T regulatory cells, endothelial precursor cells, preadipocytes, as well as anti-inflammatory M2 macrophages. Safety of autologous adipose tissue implantation is supported by extensive use of this procedure in cosmetic surgery, as well as by ongoing studies using in vitro expanded adipose derived MSC. Equine and canine studies demonstrating anti-inflammatory and regenerative effects of non-expanded SVF cells have yielded promising results. Although non-expanded SVF cells have been used successfully in accelerating healing of Crohn's fistulas, to our knowledge clinical use of these cells for systemic immune modulation has not been reported. In this communication we discuss the rationale for use of autologous SVF in treatment of multiple sclerosis and describe our experiences with three patients. Based on this rationale and initial experiences, we propose controlled trials of autologous SVF in various inflammatory conditions.

AB - The stromal vascular fraction (SVF) of adipose tissue is known to contain mesenchymal stem cells (MSC), T regulatory cells, endothelial precursor cells, preadipocytes, as well as anti-inflammatory M2 macrophages. Safety of autologous adipose tissue implantation is supported by extensive use of this procedure in cosmetic surgery, as well as by ongoing studies using in vitro expanded adipose derived MSC. Equine and canine studies demonstrating anti-inflammatory and regenerative effects of non-expanded SVF cells have yielded promising results. Although non-expanded SVF cells have been used successfully in accelerating healing of Crohn's fistulas, to our knowledge clinical use of these cells for systemic immune modulation has not been reported. In this communication we discuss the rationale for use of autologous SVF in treatment of multiple sclerosis and describe our experiences with three patients. Based on this rationale and initial experiences, we propose controlled trials of autologous SVF in various inflammatory conditions.

UR - http://www.scopus.com/inward/record.url?scp=65649144789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649144789&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-7-29

DO - 10.1186/1479-5876-7-29

M3 - Article

C2 - 19393041

AN - SCOPUS:65649144789

VL - 7

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

M1 - 29

ER -